作者
Pedro González-Menéndez,Ira Phadke,Meagan E. Olive,Kathy L. McGraw,Jessica Platon,Julien Papoin,Hongxia Yan,Marie Daumur,Friedemann Paul,Raghavendra G. Mirmira,Axel Joly,Jérémy Galtier,Anupama Narla,Guillaume Cartron,Valérie Dardalhon,Valérie S. Zimmermann,Marc Sitbon,Thomas E. Dever,Narla Mohandas,Lydie Da Costa,Namrata D. Udeshi,Lionel Blanc,Sandrina Kinet,Naomi Taylor
摘要
Metabolic programs contribute to hematopoietic stem and progenitor cell (HSPC) fate but it is not known whether the metabolic regulation of protein synthesis controls HSPC differentiation. We discovered that SLC7A1/CAT1-dependent arginine uptake and its catabolism to spermidine control the erythroid specification of HSPCs via activation of eukaryotic translation initiation factor 5A (eIF5A). eIF5A activity is dependent on the metabolism of spermidine to hypusine and inhibiting hypusine synthesis abrogates erythropoiesis and diverts EPO-stimulated HSPCs to a myeloid fate. Proteomic profiling reveals mitochondrial translation to be a critical target of hypusinated eIF5A and induction of mitochondrial function partially rescues erythropoiesis in the absence of hypusine. Within the hypusine network, ribosomal proteins are highly enriched and we identify defective eIF5A hypusination in erythroid pathologies caused by abnormal ribosome biogenesis. Thus, eIF5A-dependent protein synthesis is critical in the branching of erythro-myeloid differentiation and attenuated eIF5A activity characterizes ribosomal protein-linked disorders of ineffective erythropoiesis.